Incyte Corporation (INCY) Stock: Falling Apart On Failed Clinical Trial

Incyte Corporation (NASDAQ: INCY) is falling apart in the market today after announcing that a Phase 3 clinical trial, in collaboration with Merck & Co., Inc. (NYSE: MRK) has ended with less-than-positive data. Of course, this struck fear in the minds of investors, sending the stock tumbling down. Today, we’ll talk about:   The clinical results; what we’re … Read more

Altra Biotherapeutics (ATRA) Stock: Gaining On Merck (MRK) Collarboration

Atara Biotherapeutics Inc (NASDAQ:ATRA) is having an incredible time in the pre-market hours this morning and for good reason. The company announced that it has entered into a collaboration with Merck & Co., Inc. (NYSE:MRK). As a result, investor excitement ensued and the stock headed upward. Of course, our partners at Trade Ideas were the … Read more

Stocks to Track: SandRidge Energy, Inc. (NYSE:SD), Merck & Co. Inc. (NYSE:MRK), Staples, Inc. (NASDAQ:SPLS), Workday, Inc. (NYSE:WDAY)

On Thursday, Shares of SandRidge Energy, Inc. (NYSE:SD), lost -0.83% to $1.20, hitting its lowest level. SandRidge Energy, has priced its formerly declared private offering of $1 billion in aggregate principal amount of senior secured notes due 2020. The offering size was raised to $1.25 billion from $1.0 billion. The Notes will bear interest at … Read more

AVEO Pharmaceuticals (AVEO) Stock | Will The Climb Continue?

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) AVEO Pharmaceuticals stock has had a great time in the market recently. Over the past three months, the stock has grown astronomically; with the increases continuing through this week. Yesterday, we saw another decent jump as the company announced a new CFO. So today, we’ll talk about the new CFO, … Read more

April Earnings To Watch | ABBV | GILD | PFE | MRK

April is more than half way over. However, the most exciting part of the month for many is soon to come! As we move into earnings season, big names in health care are getting set to release their reports. Below are a few earnings reports that I’ll be watching closely and what I expect to … Read more